AzTrials
AzTrials

Cardiac RehabilitationSharedHeartNCT05026957

A Digitally-Supported Shared Decision Making Approach for Coronary Artery Disease Patients During Cardiac Rehabilitation

A study testing SharedHeart in people with Cardiac Rehabilitation and Digital Health, run by Hasselt University at 1 site in Belgium.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Investigating the role of shared-decision making in cardiac rehabilitation Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
SharedHeart
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteBelgium
Study dates
1 Sep 2022to 31 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Have a history of coronary artery disease with or without intervention (PCI/CABG/conservative)
  • Be clinically stable without inducible ischemia or high risk ventricular arrhythmia, confirmed by the last available maximal ergospirometry test
  • Recently having started cardiac rehabilitation in Jessa Hospital Hasselt
  • Age ≥18 years
  • Willing and physically able to follow a technology-supported shared decision making program and other study procedures in a three months follow-up period
  • Show evidence of a personally signed and dated informed consent, indicating that the subject (or a legally-recognized representative) has been informed of all pertinent aspects of the study
Show all 9Show fewer
  • Possession of and/or able to use an Android based smartphone
  • Possession of internet connectivity
  • Dutch speaking and understanding

Who cannot join

  • • Orthopedic, neurologic or any other pathologic condition which makes the patient physically unable to follow a technology-supported shared decision making program
  • Planned interventional procedure or surgery in the next three months
  • Pregnant females
  • Present cardiovascular complaints
  • Participation in other cardiac rehabilitation program trials, focusing on exercise outcome
  • Current or recent participation in other technology-supported programs, even when not directly targeting exercise capacity
  • Any condition which in the opinion of the investigator would make it unsafe or unsuitable for the patient to participate in this study or a life expectancy of less than three months based on investigators judgement

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Jessa Ziekenhuis

    Hasselt

Other trials in Belgium

About this study

Official title: A Shared Decision Making Approach With Digital Support to Improve Quality of Life, Exercise Capacity, Motivation to Exercise, Perception of Rehabilitation and Engagement in the Decision Making Process in Patients With Coronary Artery Disease in a Cardiac Rehabilitation Setting

Investigating the role of shared-decision making in cardiac rehabilitation

Read the detailed description

The clinical study is a prospective double-arm, randomized controlled trial to study the user experience of the approach with the supporting applications, and the impact on patients' quality of life, physical activity, perception of rehabilitation and engagement in the decision making process.

Being tested
SharedHeart

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SharedHeartDevice

    A smartphone application

Study groups in NCT05026957
Study groupRoleWhat they receive
Control groupActive comparatorParticipating in regular cardiac rehabilitation
Receives: Device: SharedHeart
InterventionExperimentalParticipating in regular cardiac rehabilitation + using the shared-decision making application
Receives: Device: SharedHeart

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart-related Quality of Life

    The Heart-related Quality of Life will be assesed with a validated questionnaire "HeartQoL". The questionnaire will be administered to the patient at baseline and after 3 months on paper.

    Measured: 3 months

Secondary outcomes (1)
  1. Exercise capacity change

    Peak VO2 with CPET

    Measured: 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Aug 2021
  2. Study start1 Sep 2022
  3. Primary completion31 Dec 2023 (estimated)
  4. Study completion31 Dec 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
RCT
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05026957
Sponsor's protocol ID
19.09/cardio 19.03
Acronym
SharedHeart
Status last verified
Jul 2023
First submitted
12 Aug 2021
Last updated
24 Jul 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing SharedHeart in people with Cardiac Rehabilitation and Digital Health, run by Hasselt University at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 Jul 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart-related Quality of Life (time frame: 3 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Jul 2023.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in